The University of Nottingham Medical School is the medical school of the University of Nottingham, Nottingham, UK. Its first intake of 48 students graduated in 1975.

During the past decade, Haemophilia Centre, University Hospital, Queens Medical Centre, Clifton Boulevard conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Haemophilia Centre, University Hospital, Queens Medical Centre, Clifton Boulevard" are "Haemophilia A" (2 trials). Many other conditions were trialed in "Haemophilia Centre, University Hospital, Queens Medical Centre, Clifton Boulevard" in a lesser frequency.

Most popular intervention types in "Haemophilia Centre, University Hospital, Queens Medical Centre, Clifton Boulevard" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Optivate® (Human Coagulation Factor VIII)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Haemophilia Centre, University Hospital, Queens Medical Centre, Clifton Boulevard" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Haemophilia Centre, University Hospital, Queens Medical Centre, Clifton Boulevard". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Haemophilia Centre, University Hospital, Queens Medical Centre, Clifton Boulevard, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Haemophilia Centre, University Hospital, Queens Medical Centre, Clifton Boulevard, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".